/
Company and Business Strategy Overview As a global healthcare holding company, with operations in South Korea and Switzerland and an office in the United States, we intend to leverage our existing and expanding network of academic and industry leaders and investor network, including venture capital and private equity, in major healthcare markets globally to identify, lead and support the growth…
The business is unprofitable at the operating level (-631.01% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 17.7% YoY. Margins deteriorated 299.8pp alongside, both lines moving the wrong way.
Operating margin contracted 299.8pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$3M
▼ -17.7% YoY
Net Income (TTM)
-$10M
▼ -647.1% YoY
Op. Margin
-726.07%
▼ -299.8pp YoY
ROIC
-11.23%
▲ +398.7pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$5M
▼ -134.0% YoY
Net Debt
$1M
Cash & Equiv.
$2M
Continue Research